Development and validation of a novel stem cell subtype for bladder cancer based on stem genomic profiling

BACKGROUND: Bladder cancer (BLCA) is the fifth most common type of cancer worldwide, with high recurrence and progression rates. Although considerable progress has been made in the treatment of BLCA through accurate typing of molecular characteristics, little is known regarding the various genetic a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Chaozhi, Ma, Jiakang, Liu, Xiuli, Liu, Zhengchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594303/
https://www.ncbi.nlm.nih.gov/pubmed/33115513
http://dx.doi.org/10.1186/s13287-020-01973-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594303/
https://www.ncbi.nlm.nih.gov/pubmed/33115513
http://dx.doi.org/10.1186/s13287-020-01973-4

Ejemplares similares